Amphastar Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference Transcript
Our next company is Amphastar Pharmaceuticals. And with me is President, Jason Shandell. My name is Ashwani Verma. I'm with the U.S. major and specialty pharmaceuticals team with the Bank of America.
And Jason, just over to you. Let's take a look at the slides.
Great. Great. Thank you. So I'll just get the light -- okay, there we go. So just going to go through the slides. I know we only have a short amount of time and then can open it up for some quick Q&A.
And so let's go through the forward-looking statements. So essentially, Amphastar, we're headquartered in Rancho Cucamonga. That's east of downtown L.A., about 1 hour. We're very well known for enoxaparin -- is still one of our largest revenue products. We were approved in 2011, have always been proud of that approval. It really is a testament to our scientific capabilities with characterization and immunogenicity.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |